Akero Therapeutics Cash from Financing (TTM)

Akero Therapeutics Inc (AKRO)

38.26

+0.46 (+1.22%) USD | NASDAQ | Mar 31, 16:00

38.24

-0.02 (-0.05%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2022	255.63M
September 30, 2022	253.15M
June 30, 2022	35.32M
March 31, 2022	0.71M
December 31, 2021	0.602M
September 30, 2021	0.418M
June 30, 2021	203.13M
March 31, 2021	202.97M
December 31, 2020	203.11M

Date	Value
September 30, 2020	203.16M
June 30, 2020	-1.228M
March 31, 2020	96.87M
December 31, 2019	95.99M
September 30, 2019	166.10M
June 30, 2019	167.70M
March 31, 2019	84.29M
December 31, 2018	85.01M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.228M

Minimum

Jun 2020

255.63M

Maximum

Dec 2022

120.76M

Average

96.87M

Median

Mar 2020

Cash from Financing (TTM) Benchmarks